However, an increasing number of studies have found that G-CSF enhances the pro-tumor effects of MDSCs, thereby leading to poor prognosis and chemoresistance in cancers (Hollmén et al., 2016; Liu et al., 2020; Karagiannidis et al., 2021). This evidence concerns the gene CSF3 and cancer.